CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Johnson Pharmacare Ltd.

NSE : BSE : 532154 ISIN CODE : INE560F01022Industry : Services - Others

News

  • Johnson Pharmacare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 20 Apr 2026 | 16:50 | Dion Global

    As of March 2026 100.00% owned by Public.more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Resignation of Director 17 Apr 2026 | 19:20 | Dion Global

    Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Change in Management 17 Apr 2026 | 18:55 | Dion Global

    Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015\r\nAppointment of MR. Nand Kishore Ray as Additional Non -Executive &Non- Independent ...more...

  • Johnson Pharmacare - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI 17 Apr 2026 | 18:08 | Dion Global

    1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional\r\n(Non-Executive & Non-Independent Director) of the Compan...more...

  • Johnson Pharmacare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Apr 2026 | 17:50 | Dion Global

    Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations 2018 for the quarter and year ended 31st March 2026more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Change in Management 17 Feb 2026 | 18:26 | Dion Global

    Disclosure as per Regulation 30 of SEBI LODR Regualtion 2015 for the appointment of Additional Non- Executive & Independent Director.more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s 17 Feb 2026 | 18:19 | Dion Global

    Disclosure as per Regulation 30 of SEBI LODR Regulation 2015 for the appointment of Statutory Auditor.more...

  • Johnson Pharmacare - Board Meeting Outcome for Revised Outcome Of Meeting Of Board Of Directors Held On Friday, 13Th\r\nFebru 17 Feb 2026 | 17:56 | Dion Global

    Revised outcome of Meeting of Board of Directors held on Friday 13th Feburay 2026 at Pursuant to Regulation 30 of SEBI LODR Regulation 2015.more...

  • Johnson Pharmacare - Undertaking For Non-Applicability Of Regulation 32 Of SEBI (LODR)\r\nRegulations, 2015 For The Quarter E 14 Feb 2026 | 18:21 | Dion Global

    Undertaking for Non- applicability of reg 32 of sebi (lodr) regualtion 2015 for the quarter ended on 31st December 2025more...

  • Johnson Pharmacare - Submission Of Unaudited (Standalone) Financial Results Of (Johnson Pharmacare\r\nLimited) For The Quarte 14 Feb 2026 | 18:16 | Dion Global

    Submission of unaudited (Stanalone) Financials results of (Johnson Pharmacare Limited) for the quarter ended on 31st December 2025 along wit...more...

  • Johnson Pharmacare - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 14Th February, 2026 As Per\r\nRegul 14 Feb 2026 | 18:06 | Dion Global

    UNAUDITED (STANDALONE) FINANCIAL RESULTS\r\nThe Board of Director have considered and approved the Unaudited (Standalone) Financial\r\nResults along ...more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Change in Management 13 Feb 2026 | 13:58 | Dion Global

    Disclosure as per Regulation 30 of SEBI (LODR) Regulations 2015 \r\nAppointment of Parul Agrawal as Additional (Non-Executive Independent Di...more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s 13 Feb 2026 | 13:48 | Dion Global

    Disclosure under Regulation 30 of SEBI (LODR) regarding appointmrent of M/S VRSK & Associates as Statutory Auditors of the Company .more...

  • Johnson Pharmacare - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Friday, 13Th February, 2026\r 13 Feb 2026 | 13:01 | Dion Global

    1. The Board of Director have considered and approved the appointment of M/S. VRSK &\r\nAssociates (FRN:011199N) as Statutory Auditor of the...more...

  • Johnson Pharmacare - Board Meeting Intimation for Intimation For The Postponement Of Board Meeting 12 Feb 2026 | 18:21 | Dion Global

    Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider an...more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Change in Management 09 Feb 2026 | 18:37 | Dion Global

    Disclosure as per Regulation 30 of SEBI (LODR) Regulations 2015\r\nAppointment of Mr. Umesh kumar as an Additional Executive Director of the company.more...

  • Johnson Pharmacare - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI 09 Feb 2026 | 18:07 | Dion Global

    The Board has appointed Mr. Umesh Kumar (DIN: 07015921) as an Additional Executive\r\nDirector of the Company w.e.f 09th February 2026 a brief profil...more...

  • Johnson Pharmacare - Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited Financial\r\nR 05 Feb 2026 | 18:18 | Dion Global

    Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to co...more...

  • Johnson Pharmacare - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address 02 Feb 2026 | 16:57 | Dion Global

    Disclosure of Change of Corporate Office Pursuant to Regualtion 30 of the SEBI (LODR) Regulations 2015more...

  • Johnson Pharmacare - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI 02 Feb 2026 | 16:33 | Dion Global

    The board has considered and approve the removal of the Corporate Office 1002 10th Floor \r\nVikram Tower Rajendra Place New Delhi-110060. R...more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex77051.89-0.33%
NSE Index24085.95-0.02%
B500DIVL503689.370.47%
BSE 1000 10627.5-0.11%
BSE 100LCTMC9032.08-0.20%
BSE Auto 57136.26-0.70%

Commodity

Gold1506720.31%
Silver2438391.18%
Copper1291.5216.70%
Crude Oil908041.59%
Lead200.9549.52%
Mentha Oil1113.14.28%
Nickel1820.4137.37%

Currency

USD/INR 94.30(0.23 %)
GBP/INR 126.95(0.00 %)
EUR/INR 110.14(0.00 %)
JPY/INR 0.59(0.11 %)
CAD/INR 68.68(0.00 %)
HKD/INR 12.01(-0.01 %)